Td Asset Management Inc Icosavax, Inc. Transaction History

Td Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$5.95 - $15.79 $83,300 - $221,060	-14,000 Reduced 24.51%	43,118 $679,000
Q2 2023 Aug 09, 2023	BUY	$4.89 - $10.57 $18,083 - $39,087	3,698 Added 6.92%	57,118 $567,000
Q1 2023 May 10, 2023	BUY	$5.62 - $11.51 $56,200 - $115,100	10,000 Added 23.03%	53,420 $309,000
Q3 2022 Nov 07, 2022	SELL	$3.09 - $9.21 $16,605 - $49,494	-5,374 Reduced 11.01%	43,420 $134,000
Q2 2022 Aug 04, 2022	BUY	$5.7 - $10.33 $100,365 - $181,890	17,608 Added 56.46%	48,794 $280,000
Q1 2022 May 10, 2022	SELL	$4.41 - $22.5 $36,188 - $184,635	-8,206 Reduced 20.83%	31,186 $220,000
Q4 2021 Feb 10, 2022	BUY	$21.07 - $34.98 $513,349 - $852,252	24,364 Added 162.12%	39,392 $901,000
Q3 2021 Nov 09, 2021	BUY	$24.85 - $40.25 $373,445 - $604,877	15,028 New	15,028 $445,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.